| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenols | 6 | 2018 | 76 | 2.740 |
Why?
|
| Adrenocortical Hyperfunction | 4 | 2018 | 4 | 2.190 |
Why?
|
| Corticosterone | 7 | 2018 | 73 | 1.660 |
Why?
|
| Nanotechnology | 11 | 2015 | 150 | 1.350 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 2 | 2018 | 17 | 1.240 |
Why?
|
| Aminopyridines | 2 | 2018 | 13 | 1.230 |
Why?
|
| Sulfonamides | 2 | 2018 | 75 | 1.180 |
Why?
|
| Phosphoproteins | 7 | 2012 | 154 | 1.120 |
Why?
|
| Zona Fasciculata | 4 | 2010 | 4 | 1.110 |
Why?
|
| Zona Reticularis | 3 | 2010 | 3 | 1.050 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2018 | 1534 | 1.040 |
Why?
|
| Pregnenolone | 6 | 2012 | 10 | 0.970 |
Why?
|
| Fluorescent Dyes | 4 | 2014 | 173 | 0.920 |
Why?
|
| Animals | 51 | 2020 | 14307 | 0.900 |
Why?
|
| Nanostructures | 8 | 2018 | 133 | 0.880 |
Why?
|
| Nanoparticles | 11 | 2018 | 294 | 0.880 |
Why?
|
| Antineoplastic Agents | 10 | 2018 | 756 | 0.860 |
Why?
|
| Testosterone | 2 | 2016 | 181 | 0.860 |
Why?
|
| Neoplasms | 11 | 2020 | 1033 | 0.850 |
Why?
|
| Digitoxin | 2 | 2021 | 7 | 0.850 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2015 | 468 | 0.830 |
Why?
|
| Granulosa Cells | 2 | 2012 | 34 | 0.800 |
Why?
|
| Drug Resistance, Neoplasm | 8 | 2017 | 209 | 0.760 |
Why?
|
| Immunotoxins | 3 | 2017 | 11 | 0.740 |
Why?
|
| Cystic Fibrosis | 5 | 2019 | 19 | 0.720 |
Why?
|
| Transferrin | 4 | 2017 | 31 | 0.690 |
Why?
|
| Rats | 16 | 2015 | 3261 | 0.670 |
Why?
|
| Luminescent Measurements | 2 | 2008 | 26 | 0.660 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2017 | 242 | 0.620 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 303 | 0.610 |
Why?
|
| Breast Neoplasms | 10 | 2016 | 1426 | 0.610 |
Why?
|
| Adiposity | 1 | 2018 | 145 | 0.600 |
Why?
|
| Cell Line, Tumor | 22 | 2020 | 2128 | 0.590 |
Why?
|
| Nanomedicine | 6 | 2015 | 32 | 0.570 |
Why?
|
| Progesterone | 5 | 2012 | 117 | 0.560 |
Why?
|
| Amphetamine | 1 | 2015 | 15 | 0.550 |
Why?
|
| Metal Nanoparticles | 6 | 2014 | 180 | 0.540 |
Why?
|
| Endocrine Disruptors | 2 | 2014 | 38 | 0.540 |
Why?
|
| Spleen | 1 | 2016 | 192 | 0.540 |
Why?
|
| Plant Extracts | 2 | 2009 | 250 | 0.530 |
Why?
|
| Adipose Tissue | 6 | 2018 | 167 | 0.530 |
Why?
|
| Head and Neck Neoplasms | 3 | 2015 | 73 | 0.510 |
Why?
|
| Maternal Exposure | 1 | 2014 | 30 | 0.500 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 240 | 0.500 |
Why?
|
| Drug Delivery Systems | 5 | 2016 | 182 | 0.490 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 325 | 0.480 |
Why?
|
| Dopamine | 1 | 2015 | 232 | 0.480 |
Why?
|
| Male | 24 | 2021 | 18870 | 0.470 |
Why?
|
| Female | 32 | 2021 | 19873 | 0.470 |
Why?
|
| Humans | 59 | 2021 | 34853 | 0.470 |
Why?
|
| Molecular Imaging | 2 | 2013 | 30 | 0.460 |
Why?
|
| Cisplatin | 5 | 2013 | 70 | 0.460 |
Why?
|
| Glucosamine | 1 | 2012 | 5 | 0.450 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 5 | 2010 | 7 | 0.430 |
Why?
|
| Mice | 19 | 2020 | 5668 | 0.430 |
Why?
|
| Adrenocorticotropic Hormone | 5 | 2012 | 23 | 0.430 |
Why?
|
| Contrast Media | 3 | 2013 | 95 | 0.430 |
Why?
|
| Leydig Cells | 2 | 2009 | 5 | 0.420 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 95 | 0.420 |
Why?
|
| Gold | 4 | 2014 | 134 | 0.420 |
Why?
|
| Brain | 3 | 2015 | 1268 | 0.420 |
Why?
|
| Sputum | 5 | 2019 | 16 | 0.410 |
Why?
|
| Aldosterone | 3 | 2018 | 62 | 0.400 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 181 | 0.400 |
Why?
|
| Drug Carriers | 4 | 2016 | 121 | 0.400 |
Why?
|
| Propylthiouracil | 1 | 2010 | 3 | 0.390 |
Why?
|
| Cell Differentiation | 2 | 2017 | 562 | 0.390 |
Why?
|
| Gadolinium | 4 | 2011 | 27 | 0.390 |
Why?
|
| Cetacea | 2 | 2020 | 3 | 0.380 |
Why?
|
| Oculomotor Muscles | 2 | 2020 | 13 | 0.380 |
Why?
|
| Indole Alkaloids | 1 | 2009 | 12 | 0.370 |
Why?
|
| Fullerenes | 4 | 2011 | 30 | 0.360 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 54 | 0.360 |
Why?
|
| Biology | 1 | 2009 | 15 | 0.360 |
Why?
|
| Quinazolines | 1 | 2009 | 31 | 0.360 |
Why?
|
| Mice, Nude | 9 | 2017 | 323 | 0.350 |
Why?
|
| International Cooperation | 1 | 2009 | 44 | 0.350 |
Why?
|
| Congresses as Topic | 1 | 2009 | 38 | 0.350 |
Why?
|
| Body Weight | 5 | 2016 | 404 | 0.350 |
Why?
|
| Magnetic Resonance Spectroscopy | 11 | 2020 | 281 | 0.350 |
Why?
|
| Liver | 3 | 2018 | 447 | 0.340 |
Why?
|
| Mammary Glands, Animal | 1 | 2008 | 25 | 0.330 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 4 | 2010 | 16 | 0.320 |
Why?
|
| Infrared Rays | 1 | 2008 | 18 | 0.320 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 30 | 0.320 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 210 | 0.310 |
Why?
|
| Pseudomonas Infections | 2 | 2019 | 18 | 0.310 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 794 | 0.310 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 1300 | 0.300 |
Why?
|
| PPAR alpha | 2 | 2018 | 42 | 0.300 |
Why?
|
| Coix | 1 | 2006 | 1 | 0.300 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2019 | 57 | 0.290 |
Why?
|
| Polymers | 4 | 2020 | 117 | 0.290 |
Why?
|
| Cell Line | 5 | 2021 | 1289 | 0.290 |
Why?
|
| Pregnancy | 3 | 2018 | 1503 | 0.290 |
Why?
|
| Cells, Cultured | 4 | 2018 | 1442 | 0.290 |
Why?
|
| Cell Proliferation | 4 | 2021 | 1149 | 0.270 |
Why?
|
| Endocytosis | 3 | 2012 | 104 | 0.270 |
Why?
|
| Polyethylene Glycols | 3 | 2017 | 80 | 0.270 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 3 | 2010 | 7 | 0.260 |
Why?
|
| Desoxycorticosterone | 3 | 2010 | 9 | 0.260 |
Why?
|
| Hydroxycholesterols | 3 | 2010 | 12 | 0.260 |
Why?
|
| Epithelial Cells | 1 | 2008 | 366 | 0.260 |
Why?
|
| Mitochondria | 4 | 2012 | 454 | 0.260 |
Why?
|
| Digoxin | 2 | 2021 | 6 | 0.250 |
Why?
|
| Lung | 3 | 2015 | 413 | 0.240 |
Why?
|
| Nanospheres | 2 | 2020 | 7 | 0.230 |
Why?
|
| Bacteria | 2 | 2019 | 245 | 0.220 |
Why?
|
| Sesquiterpenes | 1 | 2002 | 30 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 2 | 2014 | 74 | 0.220 |
Why?
|
| Digitalis Glycosides | 1 | 2002 | 1 | 0.210 |
Why?
|
| Luteal Cells | 1 | 2002 | 1 | 0.210 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 257 | 0.210 |
Why?
|
| Biocompatible Materials | 2 | 2014 | 75 | 0.210 |
Why?
|
| Blotting, Western | 3 | 2016 | 834 | 0.210 |
Why?
|
| Hippocampus | 2 | 2020 | 546 | 0.210 |
Why?
|
| Cell Cycle | 2 | 2021 | 309 | 0.200 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 21 | 0.190 |
Why?
|
| Antigens | 1 | 2020 | 56 | 0.190 |
Why?
|
| Delayed-Action Preparations | 1 | 2020 | 57 | 0.190 |
Why?
|
| Camptothecin | 2 | 2017 | 20 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2015 | 176 | 0.190 |
Why?
|
| Nanotubes | 2 | 2017 | 18 | 0.190 |
Why?
|
| Photochemotherapy | 2 | 2017 | 37 | 0.190 |
Why?
|
| Orbit | 1 | 2019 | 9 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2016 | 1802 | 0.180 |
Why?
|
| Biological Transport | 2 | 2018 | 175 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 455 | 0.180 |
Why?
|
| Fluorescence | 3 | 2014 | 117 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 206 | 0.180 |
Why?
|
| Sirtuins | 1 | 2019 | 12 | 0.180 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2019 | 1 | 0.180 |
Why?
|
| beta-Lactam Resistance | 1 | 2019 | 4 | 0.170 |
Why?
|
| beta-Lactams | 1 | 2019 | 4 | 0.170 |
Why?
|
| Sarcoma, Kaposi | 1 | 2019 | 20 | 0.170 |
Why?
|
| Herpesvirus 8, Human | 1 | 2019 | 25 | 0.170 |
Why?
|
| Tissue Distribution | 3 | 2015 | 197 | 0.170 |
Why?
|
| Immediate-Early Proteins | 1 | 2019 | 45 | 0.170 |
Why?
|
| Escherichia coli | 3 | 2009 | 436 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 484 | 0.170 |
Why?
|
| Radioimmunoassay | 2 | 2009 | 66 | 0.170 |
Why?
|
| Pneumonia | 1 | 2019 | 50 | 0.160 |
Why?
|
| Drug Resistance, Multiple | 3 | 2017 | 26 | 0.160 |
Why?
|
| Cytotoxins | 1 | 2018 | 10 | 0.160 |
Why?
|
| PPAR gamma | 1 | 2018 | 49 | 0.160 |
Why?
|
| Platinum | 1 | 2018 | 18 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2019 | 167 | 0.160 |
Why?
|
| Adipocytes | 1 | 2018 | 54 | 0.160 |
Why?
|
| Prodrugs | 1 | 2018 | 22 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 3 | 0.160 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 36 | 0.160 |
Why?
|
| Breast | 3 | 2016 | 134 | 0.160 |
Why?
|
| Oligodendroglia | 1 | 2017 | 20 | 0.160 |
Why?
|
| Viral Proteins | 1 | 2019 | 172 | 0.160 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 105 | 0.160 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 22 | 0.160 |
Why?
|
| Frontal Lobe | 1 | 2017 | 49 | 0.160 |
Why?
|
| Anthropometry | 1 | 1997 | 91 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2013 | 360 | 0.150 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 336 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 984 | 0.150 |
Why?
|
| Nanofibers | 1 | 2017 | 11 | 0.150 |
Why?
|
| Porphyrins | 1 | 2017 | 53 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2017 | 49 | 0.150 |
Why?
|
| Brain Ischemia | 2 | 2010 | 179 | 0.150 |
Why?
|
| Organ Size | 2 | 2016 | 148 | 0.140 |
Why?
|
| Mammography | 3 | 2008 | 176 | 0.140 |
Why?
|
| Orchiectomy | 1 | 2016 | 33 | 0.140 |
Why?
|
| Adrenal Glands | 1 | 2016 | 17 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 3 | 2019 | 430 | 0.140 |
Why?
|
| Organoplatinum Compounds | 2 | 2013 | 15 | 0.140 |
Why?
|
| Receptors, Transferrin | 3 | 2017 | 12 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2015 | 12 | 0.140 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 114 | 0.140 |
Why?
|
| Holoprosencephaly | 1 | 2015 | 5 | 0.140 |
Why?
|
| Adiponectin | 1 | 2016 | 52 | 0.140 |
Why?
|
| Carbazoles | 1 | 2016 | 43 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2015 | 165 | 0.140 |
Why?
|
| Genetic Variation | 2 | 2015 | 328 | 0.140 |
Why?
|
| Photosensitizing Agents | 1 | 2016 | 47 | 0.140 |
Why?
|
| Surface-Active Agents | 1 | 2015 | 41 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 90 | 0.140 |
Why?
|
| Prolactin | 1 | 2015 | 59 | 0.140 |
Why?
|
| Cyclic AMP | 2 | 2009 | 125 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 355 | 0.140 |
Why?
|
| Body Composition | 4 | 2001 | 146 | 0.130 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 56 | 0.130 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2014 | 3 | 0.130 |
Why?
|
| Face | 1 | 2015 | 49 | 0.130 |
Why?
|
| Angiotensin II | 1 | 2015 | 92 | 0.130 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2014 | 4 | 0.130 |
Why?
|
| Curcumin | 1 | 2015 | 66 | 0.130 |
Why?
|
| Gene Expression | 2 | 2015 | 639 | 0.130 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 200 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2014 | 50 | 0.120 |
Why?
|
| Myoblasts | 1 | 2014 | 25 | 0.120 |
Why?
|
| Apoptosis | 5 | 2018 | 1317 | 0.120 |
Why?
|
| Osteopontin | 1 | 2014 | 35 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2014 | 89 | 0.120 |
Why?
|
| Chemotaxis | 2 | 1986 | 57 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 286 | 0.120 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 249 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1152 | 0.120 |
Why?
|
| Cell Survival | 5 | 2015 | 818 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 165 | 0.110 |
Why?
|
| Cytochromes c | 1 | 2012 | 45 | 0.110 |
Why?
|
| DNA | 1 | 2016 | 549 | 0.110 |
Why?
|
| Hyperthermia, Induced | 1 | 2012 | 17 | 0.110 |
Why?
|
| Reactive Oxygen Species | 3 | 2012 | 416 | 0.110 |
Why?
|
| Drugs, Chinese Herbal | 2 | 2009 | 20 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2012 | 28 | 0.110 |
Why?
|
| Optical Devices | 1 | 2012 | 4 | 0.110 |
Why?
|
| Aorta, Abdominal | 2 | 2011 | 10 | 0.110 |
Why?
|
| Metagenome | 1 | 2012 | 28 | 0.110 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 24 | 0.110 |
Why?
|
| DNA, Bacterial | 4 | 2015 | 184 | 0.110 |
Why?
|
| Liposomes | 3 | 2008 | 107 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2014 | 351 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2012 | 13 | 0.110 |
Why?
|
| Pseudomonas syringae | 1 | 2012 | 9 | 0.110 |
Why?
|
| Acetyltransferases | 1 | 2012 | 26 | 0.110 |
Why?
|
| Nanotubes, Carbon | 1 | 2012 | 67 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 649 | 0.100 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2012 | 50 | 0.100 |
Why?
|
| Nanocapsules | 1 | 2011 | 16 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2011 | 40 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2012 | 98 | 0.100 |
Why?
|
| Crystallization | 1 | 2011 | 82 | 0.100 |
Why?
|
| Nylons | 1 | 2010 | 2 | 0.100 |
Why?
|
| Methacrylates | 1 | 2010 | 4 | 0.100 |
Why?
|
| Oxidative Stress | 3 | 2012 | 874 | 0.100 |
Why?
|
| Muscular Atrophy | 1 | 2010 | 12 | 0.100 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2010 | 6 | 0.100 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2010 | 2 | 0.100 |
Why?
|
| Cell Extracts | 1 | 2010 | 16 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2011 | 140 | 0.100 |
Why?
|
| Cell Fractionation | 1 | 2010 | 28 | 0.100 |
Why?
|
| Microtubules | 1 | 2012 | 113 | 0.100 |
Why?
|
| Polyesters | 1 | 2010 | 21 | 0.100 |
Why?
|
| Arabidopsis | 1 | 2012 | 88 | 0.100 |
Why?
|
| Kinetics | 1 | 2012 | 650 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 27 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 155 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 127 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2011 | 87 | 0.100 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 55 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 66 | 0.090 |
Why?
|
| Flavonoids | 1 | 2010 | 78 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 217 | 0.090 |
Why?
|
| Evodia | 1 | 2009 | 2 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2015 | 386 | 0.090 |
Why?
|
| Transfection | 3 | 2017 | 496 | 0.090 |
Why?
|
| Obesity | 1 | 1997 | 965 | 0.090 |
Why?
|
| Cholesterol | 1 | 2010 | 194 | 0.090 |
Why?
|
| Benzofurans | 1 | 2009 | 19 | 0.090 |
Why?
|
| Automation | 1 | 2009 | 25 | 0.090 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 34 | 0.090 |
Why?
|
| beta-Lactamases | 1 | 2009 | 33 | 0.090 |
Why?
|
| Cytoprotection | 1 | 2008 | 32 | 0.090 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2008 | 9 | 0.090 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 92 | 0.080 |
Why?
|
| China | 1 | 2009 | 178 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2008 | 10 | 0.080 |
Why?
|
| Caseins | 1 | 2008 | 13 | 0.080 |
Why?
|
| Escherichia coli Infections | 1 | 2009 | 39 | 0.080 |
Why?
|
| Swine | 3 | 2001 | 182 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2008 | 31 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 396 | 0.080 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 65 | 0.080 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 44 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2008 | 18 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 490 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2008 | 38 | 0.080 |
Why?
|
| Time Factors | 4 | 2017 | 1681 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 445 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 68 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 342 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2009 | 528 | 0.080 |
Why?
|
| Whole Body Imaging | 1 | 2008 | 25 | 0.080 |
Why?
|
| Luciferases | 1 | 2008 | 62 | 0.080 |
Why?
|
| Motor Activity | 1 | 2010 | 393 | 0.080 |
Why?
|
| Exocytosis | 1 | 2008 | 45 | 0.080 |
Why?
|
| Adaptation, Biological | 2 | 2019 | 23 | 0.080 |
Why?
|
| Optics and Photonics | 1 | 2007 | 25 | 0.080 |
Why?
|
| Molecular Probes | 1 | 2007 | 23 | 0.080 |
Why?
|
| Magnetics | 1 | 2007 | 36 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 117 | 0.080 |
Why?
|
| Peptide Hormones | 1 | 2006 | 19 | 0.070 |
Why?
|
| Acetone | 1 | 2006 | 6 | 0.070 |
Why?
|
| Dihydrotestosterone | 1 | 2006 | 26 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 480 | 0.070 |
Why?
|
| Genotype | 3 | 2015 | 641 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2006 | 53 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2006 | 82 | 0.070 |
Why?
|
| Doxorubicin | 2 | 2017 | 80 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 1530 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 391 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 841 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2015 | 188 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2017 | 154 | 0.070 |
Why?
|
| Injections, Intravenous | 2 | 2002 | 58 | 0.070 |
Why?
|
| Subtraction Technique | 1 | 2004 | 7 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2019 | 226 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2004 | 10 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 255 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2004 | 30 | 0.060 |
Why?
|
| Rats, Wistar | 3 | 2011 | 202 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 106 | 0.060 |
Why?
|
| Membrane Fluidity | 1 | 2004 | 11 | 0.060 |
Why?
|
| Models, Animal | 2 | 2017 | 131 | 0.060 |
Why?
|
| Cell Death | 2 | 2015 | 260 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2015 | 196 | 0.060 |
Why?
|
| Models, Biological | 4 | 2012 | 642 | 0.060 |
Why?
|
| Carcinoma | 1 | 2004 | 94 | 0.060 |
Why?
|
| Colony-Forming Units Assay | 2 | 2015 | 12 | 0.060 |
Why?
|
| Surface Properties | 2 | 2013 | 121 | 0.060 |
Why?
|
| Hep G2 Cells | 2 | 2014 | 52 | 0.060 |
Why?
|
| Age Factors | 2 | 2017 | 1007 | 0.060 |
Why?
|
| Body Water | 2 | 2020 | 26 | 0.060 |
Why?
|
| Light | 3 | 2013 | 180 | 0.050 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2002 | 2 | 0.050 |
Why?
|
| Ouabain | 1 | 2002 | 15 | 0.050 |
Why?
|
| Hormone Antagonists | 1 | 2002 | 15 | 0.050 |
Why?
|
| Mifepristone | 1 | 2002 | 33 | 0.050 |
Why?
|
| Algorithms | 1 | 2004 | 435 | 0.050 |
Why?
|
| Particle Size | 2 | 2012 | 200 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2015 | 392 | 0.050 |
Why?
|
| Lipids | 2 | 2020 | 222 | 0.050 |
Why?
|
| Postmortem Changes | 1 | 2020 | 19 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2020 | 18 | 0.050 |
Why?
|
| Microwaves | 1 | 2020 | 26 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2012 | 71 | 0.050 |
Why?
|
| Random Allocation | 1 | 2020 | 139 | 0.050 |
Why?
|
| Protons | 1 | 2020 | 80 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2013 | 138 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2020 | 91 | 0.040 |
Why?
|
| United States | 1 | 2009 | 3894 | 0.040 |
Why?
|
| Child | 2 | 2019 | 2875 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1130 | 0.040 |
Why?
|
| Virus Latency | 1 | 2019 | 42 | 0.040 |
Why?
|
| Metagenomics | 1 | 2019 | 32 | 0.040 |
Why?
|
| Scattering, Radiation | 2 | 2013 | 45 | 0.040 |
Why?
|
| Regression Analysis | 2 | 1997 | 429 | 0.040 |
Why?
|
| Canada | 1 | 2019 | 121 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 122 | 0.040 |
Why?
|
| Oxygen | 2 | 2012 | 193 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 80 | 0.040 |
Why?
|
| Flurbiprofen | 1 | 2018 | 10 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2019 | 108 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 11034 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 203 | 0.040 |
Why?
|
| DNA Replication | 1 | 2019 | 148 | 0.040 |
Why?
|
| Lipid Peroxidation | 2 | 2008 | 131 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 1997 | 7 | 0.040 |
Why?
|
| Chlorophyllides | 1 | 2017 | 1 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2012 | 1349 | 0.040 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2017 | 4 | 0.040 |
Why?
|
| Biological Assay | 1 | 2018 | 56 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 18 | 0.040 |
Why?
|
| Anisotropy | 1 | 2017 | 24 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2017 | 21 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 18 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 1997 | 73 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2019 | 295 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 781 | 0.040 |
Why?
|
| Micelles | 1 | 2017 | 31 | 0.040 |
Why?
|
| Virus Replication | 1 | 2019 | 261 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 287 | 0.040 |
Why?
|
| Vitamin E | 1 | 2017 | 56 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2012 | 347 | 0.040 |
Why?
|
| Hela Cells | 2 | 2010 | 344 | 0.040 |
Why?
|
| Energy Metabolism | 2 | 2014 | 160 | 0.040 |
Why?
|
| Photobleaching | 1 | 2016 | 4 | 0.040 |
Why?
|
| Plasmids | 1 | 2017 | 233 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 195 | 0.030 |
Why?
|
| Ibuprofen | 1 | 1996 | 33 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 406 | 0.030 |
Why?
|
| Microglia | 1 | 2017 | 152 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 485 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2015 | 34 | 0.030 |
Why?
|
| Sodium Cyanide | 1 | 1995 | 3 | 0.030 |
Why?
|
| Cadaver | 1 | 2015 | 41 | 0.030 |
Why?
|
| Water | 1 | 2018 | 283 | 0.030 |
Why?
|
| Astrocytes | 1 | 2017 | 203 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 12 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2015 | 42 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2015 | 66 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 129 | 0.030 |
Why?
|
| Isoquinolines | 1 | 1995 | 40 | 0.030 |
Why?
|
| Breast Diseases | 2 | 1985 | 6 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 171 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 4 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 859 | 0.030 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2014 | 9 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2015 | 72 | 0.030 |
Why?
|
| Fumarates | 1 | 2014 | 11 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 112 | 0.030 |
Why?
|
| Inorganic Chemicals | 1 | 2014 | 2 | 0.030 |
Why?
|
| Gestational Age | 1 | 2015 | 190 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2014 | 94 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 61 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2015 | 114 | 0.030 |
Why?
|
| Piperazines | 1 | 1995 | 109 | 0.030 |
Why?
|
| Biodiversity | 1 | 2015 | 81 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 4012 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1995 | 110 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2014 | 35 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 117 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2014 | 48 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 2014 | 21 | 0.030 |
Why?
|
| Asphyxia Neonatorum | 1 | 1994 | 5 | 0.030 |
Why?
|
| Mathematics | 2 | 1986 | 42 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 1994 | 7 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 43 | 0.030 |
Why?
|
| Microscopy, Scanning Tunneling | 1 | 2013 | 2 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 52 | 0.030 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2013 | 35 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 2013 | 44 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2014 | 135 | 0.030 |
Why?
|
| Technology, Pharmaceutical | 1 | 2013 | 25 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2013 | 60 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2013 | 59 | 0.030 |
Why?
|
| Brain Edema | 1 | 1994 | 62 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 145 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 65 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 143 | 0.030 |
Why?
|
| KB Cells | 1 | 2012 | 7 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 284 | 0.030 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 84 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2012 | 33 | 0.030 |
Why?
|
| Electroencephalography | 1 | 1994 | 108 | 0.030 |
Why?
|
| Diffusion | 1 | 2012 | 49 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 286 | 0.030 |
Why?
|
| Static Electricity | 1 | 2012 | 75 | 0.030 |
Why?
|
| Materials Testing | 1 | 2012 | 71 | 0.030 |
Why?
|
| Electron Transport | 1 | 2012 | 38 | 0.030 |
Why?
|
| Estrogens | 1 | 2014 | 190 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 751 | 0.030 |
Why?
|
| Phytic Acid | 1 | 2012 | 3 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 580 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 1994 | 153 | 0.030 |
Why?
|
| RNA | 1 | 2014 | 234 | 0.030 |
Why?
|
| Turkeys | 1 | 1991 | 2 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 650 | 0.030 |
Why?
|
| Acetylation | 1 | 2012 | 94 | 0.030 |
Why?
|
| Streptozocin | 1 | 2011 | 21 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2011 | 34 | 0.030 |
Why?
|
| Arabidopsis Proteins | 1 | 2012 | 38 | 0.030 |
Why?
|
| Tubulin | 1 | 2012 | 80 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2011 | 44 | 0.030 |
Why?
|
| Plant Diseases | 1 | 2012 | 52 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 550 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1353 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 20 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1318 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2010 | 14 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2010 | 27 | 0.020 |
Why?
|
| Chickens | 1 | 1991 | 123 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2010 | 19 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 23 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2010 | 42 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 247 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2010 | 18 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 76 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1989 | 8 | 0.020 |
Why?
|
| Catheterization | 1 | 1989 | 23 | 0.020 |
Why?
|
| Salvia miltiorrhiza | 1 | 2009 | 5 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 198 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 577 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2009 | 21 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2009 | 33 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 612 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 87 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 18 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2009 | 27 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2009 | 57 | 0.020 |
Why?
|
| Picrates | 1 | 2008 | 7 | 0.020 |
Why?
|
| Singlet Oxygen | 1 | 2008 | 4 | 0.020 |
Why?
|
| Hydroxyl Radical | 1 | 2008 | 15 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2008 | 34 | 0.020 |
Why?
|
| Hydrazines | 1 | 2008 | 21 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 524 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2009 | 65 | 0.020 |
Why?
|
| Caspases | 1 | 2009 | 132 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 245 | 0.020 |
Why?
|
| Superoxides | 1 | 2008 | 51 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 52 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 18 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 310 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2008 | 79 | 0.020 |
Why?
|
| District of Columbia | 1 | 2008 | 68 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2008 | 82 | 0.020 |
Why?
|
| Macrophages | 1 | 2011 | 431 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 605 | 0.020 |
Why?
|
| Ghrelin | 1 | 2006 | 12 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 126 | 0.020 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2006 | 5 | 0.020 |
Why?
|
| Microscopy, Scanning Probe | 1 | 2006 | 2 | 0.020 |
Why?
|
| K562 Cells | 1 | 2006 | 31 | 0.020 |
Why?
|
| Serine | 1 | 1986 | 72 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 239 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2006 | 18 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2006 | 62 | 0.020 |
Why?
|
| Thermography | 1 | 1984 | 10 | 0.020 |
Why?
|
| Cysts | 1 | 1984 | 8 | 0.020 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 8 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 1984 | 60 | 0.020 |
Why?
|
| Californium | 1 | 1984 | 2 | 0.020 |
Why?
|
| Physical Examination | 1 | 1984 | 40 | 0.020 |
Why?
|
| Brachytherapy | 1 | 1984 | 8 | 0.020 |
Why?
|
| Phosphates | 2 | 1995 | 49 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 30 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 5035 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1984 | 115 | 0.020 |
Why?
|
| Pyrimidinones | 1 | 2004 | 9 | 0.020 |
Why?
|
| Calcinosis | 1 | 1984 | 56 | 0.020 |
Why?
|
| Clone Cells | 1 | 2004 | 46 | 0.020 |
Why?
|
| Isoxazoles | 1 | 2004 | 11 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 59 | 0.020 |
Why?
|
| Cyclic N-Oxides | 1 | 2004 | 17 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2004 | 63 | 0.020 |
Why?
|
| Risk | 1 | 1984 | 256 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2004 | 31 | 0.020 |
Why?
|
| Potassium Channels | 1 | 2004 | 73 | 0.010 |
Why?
|
| Glioma | 1 | 1984 | 76 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 171 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 213 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 296 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 195 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2004 | 118 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 555 | 0.010 |
Why?
|
| Middle Aged | 2 | 2015 | 9642 | 0.010 |
Why?
|
| Muscles | 2 | 1993 | 64 | 0.010 |
Why?
|
| Elasticity | 1 | 1981 | 38 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 901 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 486 | 0.010 |
Why?
|
| Proteins | 2 | 1993 | 352 | 0.010 |
Why?
|
| Cell Movement | 1 | 1981 | 545 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1996 | 38 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 1995 | 8 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1995 | 8 | 0.010 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1995 | 6 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1996 | 162 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1996 | 196 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1994 | 5 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 1994 | 7 | 0.010 |
Why?
|
| Sheep | 1 | 1994 | 70 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1994 | 83 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1994 | 323 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 274 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1994 | 871 | 0.010 |
Why?
|
| Iliac Artery | 1 | 1989 | 8 | 0.010 |
Why?
|
| Renal Artery | 1 | 1989 | 7 | 0.010 |
Why?
|
| Calibration | 1 | 1989 | 55 | 0.010 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1985 | 2 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1985 | 51 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1984 | 964 | 0.000 |
Why?
|
| Aged | 1 | 1985 | 6448 | 0.000 |
Why?
|